- Home
- VCRE vs LATA Comparison
VCRE vs LATA Comparison
Compare VCRE & LATA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Company Overview
Basic Information| Metric | VCRE | LATA |
|---|---|---|
| Founded | 2000 | 2025 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Blank Checks |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 234.8M |
| IPO Year | 2026 | 2025 |
Fundamental Metrics
Financial Performance| Metric | VCRE | LATA |
|---|---|---|
| Price | $9.44 | $10.22 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $29.97 | N/A |
| AVG Volume (30 Days) | ★ 20.2K | 10.6K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $101.29 | N/A |
| Revenue Next Year | $481.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.88 | $9.91 |
| 52 Week High | $14.01 | $10.22 |
Technical Indicators
Market Signals| Indicator | VCRE | LATA |
|---|---|---|
| Relative Strength Index (RSI) | 45.55 | 62.13 |
| Support Level | $8.70 | $10.17 |
| Resistance Level | $9.64 | $10.22 |
| Average True Range (ATR) | 0.51 | 0.00 |
| MACD | 0.07 | -0.00 |
| Stochastic Oscillator | 19.38 | 80.00 |
Price Performance
Historical Comparison VCRE
LATA
About VCRE Vicore Pharma Holding AB American Depositary Shares
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
About LATA Galata Acquisition Corp. II Class A Ordinary Shares
Galata Acquisition Corp II is a blank check company.